Author

Shadia Ibrahim Jalal

Indiana University IndianapolisORCID 0000-0001-8938-7077Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Collin M. CooniD· 1 shared Daniela Elena MateiiD· 1 shared Elnaz Abbasi FaridiD· 1 shared John J. TurchiiD· 1 shared Kenneth P. NephewiD· 1 shared Reshma Bhowmick· 1 shared Shu ZhangiD· 1 shared Zhen FuiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Collin M. CoonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsPharmaceuticalsPeer-reviewedMar 28, 2026

Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients

Elnaz Abbasi Farid, Shu Zhang, Zhen Fu…·Kenneth P. Nephew

This study examines methylome changes and immune cell shifts in SCLC patients treated with guadecitabine, revealing hypomethylation and altered immune profiles.

DOI 10.3390/ph19040542

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 18, 2025

Potentiation of EGFR mutant lung cancer treatment targeting replication stress.

Reshma Bhowmick, John J. Turchi, Shadia Ibrahim Jalal

This paper shows that combining osimertinib with NERx-329, a replication stress inhibitor, enhances cell death in EGFR-mutant lung cancer cells and reduces resistance.

DOI 10.1101/2025.04.18.649510

humanbulk RNA-seq

𝕏 PostBluesky